31 related articles for article (PubMed ID: 23706267)
1. A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior.
Solidoro R; Miciaccia M; Bonaccorso C; Fortuna CG; Armenise D; Centonze A; Ferorelli S; Vitale P; Rodrigues P; Guimarães R; de Oliveira A; da Paz M; Rangel L; Sathler PC; Altomare A; Perrone MG; Scilimati A
Eur J Med Chem; 2024 Feb; 266():116135. PubMed ID: 38219659
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of New 1, 4-Dihydropyridine (DHP) Derivatives as Selective Cyclooxygenase-2 Inhibitors.
Sabakhi I; Topuzyan V; Hajimahdi Z; Daraei B; Arefi H; Zarghi A
Iran J Pharm Res; 2015; 14(4):1087-93. PubMed ID: 26664375
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of new 5,5-diarylhydantoin derivatives as selective cyclooxygenase-2 inhibitors.
Zarghi A; Javid FS; Ghodsi R; Dadrass OG; Daraei B; Hedayati M
Sci Pharm; 2011; 79(3):449-60. PubMed ID: 21886896
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, COX1/2 inhibition and molecular modeling studies on novel 2-thio-diarylimidazoles.
Şahin Z; Koçoğlu Kalkan M; Berk B; Yurttaş L; Bender C; Biltekin Kaleli SN; Demirayak Ş
Turk J Chem; 2021; 45(6):1841-1853. PubMed ID: 38144587
[TBL] [Abstract][Full Text] [Related]
5. Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor.
Hayun ; Yanuar A; Hanafi M; Pws SH
Bioinformation; 2011; 7(5):246-50. PubMed ID: 22125393
[TBL] [Abstract][Full Text] [Related]
6. Regioselective microwave synthesis and derivatization of 1,5-diaryl-3-amino-1,2,4-triazoles and a study of their cholinesterase inhibition properties.
Santos SN; Alves de Souza G; Pereira TM; Franco DP; de Nigris Del Cistia C; Sant'Anna CMR; Lacerda RB; Kümmerle AE
RSC Adv; 2019 Jun; 9(35):20356-20369. PubMed ID: 35514684
[TBL] [Abstract][Full Text] [Related]
7. Thermally Triggered Triazolinedione-Tyrosine Bioconjugation with Improved Chemo- and Site-Selectivity.
Denijs E; Unal K; Bevernaege K; Kasmi S; De Geest BG; Winne JM
J Am Chem Soc; 2024 May; 146(18):12672-12680. PubMed ID: 38683141
[TBL] [Abstract][Full Text] [Related]
8. Through-space H-F coupling in a series of 4-substituted-1H-1,2,3-triazoles.
Kempton RJ; Bradley S; Bozarth SA; Wheatcroft G; Onorato AJ; Hare PM
Magn Reson Chem; 2024 May; ():. PubMed ID: 38816347
[TBL] [Abstract][Full Text] [Related]
9. Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases.
Reddy KK; Vidya Rajan VK; Gupta A; Aparoy P; Reddanna P
BMC Res Notes; 2015 Apr; 8():152. PubMed ID: 25886468
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
Patrignani P; Patrono C
Biochim Biophys Acta; 2015 Apr; 1851(4):422-32. PubMed ID: 25263946
[TBL] [Abstract][Full Text] [Related]
11. Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective.
Chahal S; Rani P; Kiran ; Sindhu J; Joshi G; Ganesan A; Kalyaanamoorthy S; Mayank ; Kumar P; Singh R; Negi A
ACS Omega; 2023 May; 8(20):17446-17498. PubMed ID: 37251190
[TBL] [Abstract][Full Text] [Related]
12. Triazole analogues as potential pharmacological agents: a brief review.
Kumar S; Khokra SL; Yadav A
Futur J Pharm Sci; 2021; 7(1):106. PubMed ID: 34056014
[TBL] [Abstract][Full Text] [Related]
13. l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophan.
Hall C; Wolfe H; Wells A; Chien HC; Colas C; Schlessinger A; Giacomini KM; Thomas AA
Bioorg Med Chem Lett; 2019 Aug; 29(16):2254-2258. PubMed ID: 31248771
[TBL] [Abstract][Full Text] [Related]
14. The effect of some 4,2 and 5,2 bisthiazole derivatives on nitro-oxidative stress and phagocytosis in acute experimental inflammation.
Araniciu C; Pârvu AE; Palage MD; Oniga SD; Benedec D; Oniga I; Oniga O
Molecules; 2014 Jul; 19(7):9240-56. PubMed ID: 24991757
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking and fluorescence characterization of benzothieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives, a novel class of selective cyclooxygenase-2 inhibitors.
Barone M; Pannuzzo G; Santagati A; Catalfo A; De Guidi G; Cardile V
Molecules; 2014 May; 19(5):6106-22. PubMed ID: 24830713
[TBL] [Abstract][Full Text] [Related]
16. 1,4-Diaryl-substituted triazoles as cyclooxygenase-2 inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Kaur J; Bhardwaj A; Sharma SK; Wuest F
Bioorg Med Chem; 2013 Jul; 21(14):4288-95. PubMed ID: 23706267
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new rofecoxib analogs as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the methanesulfonyl pharmacophore by a N-acetylsulfonamido bioisostere.
Zarghi A; Rao PN; Knaus EE
J Pharm Pharm Sci; 2007; 10(2):159-67. PubMed ID: 17706175
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors.
Anana R; Rao PN; Chen QH; Knaus EE
Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.
Wuest F; Tang X; Kniess T; Pietzsch J; Suresh M
Bioorg Med Chem; 2009 Feb; 17(3):1146-51. PubMed ID: 19157881
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
